Creso Pharma is on its third chairman in 18 months, having lost Adam Blumenthal to an ASIC raid and his replacement James Ellingford to bizarre TikToks documenting his relationship with a much younger woman. It’s thus co-founder and current chairman Boaz Wachtel’s lot to lead Creso and Australian markets as a whole through a notable milestone. That is, the first formal censure by the ASX, issued on Monday against the listed pot stock.

A censure allows the bourse to take over a company’s news ticker and speak directly to its shareholders. Creso’s censure was revealed by the ASX on Monday afternoon. Creso rushed out its own release an hour later telling its shareholders that while it was glad the “historical” matter was now resolved, it didn’t deem the ASX’s reprimand “appropriate”.